Minovia Therapeutics Ltd. (“Minovia” or the “Company”), a clinical-stage biotechnology company developing novel therapies to treat mitochondrial diseases and combat age-related decline, announces that ...
Mitochondria, the “powerhouses of the cell,” are vital cellular organelles that govern energy metabolism, maintain redox ...
The discovery that fat is a communicative organ with a role in everything from bone health to mood is forcing a rethink of ...
Scientists have discovered a way to fully reverse acute kidney injury in mice by blocking harmful ceramide molecules that ...
Researchers uncovered how fatty molecules called ceramides trigger acute kidney injury by damaging the mitochondria that ...
A joint study by the University Medical Center Göttingen (UMG) and the University Hospital Würzburg provides new insights ...
Blocking fatty ceramides could stop acute kidney injury—and possibly revolutionize mitochondrial disease treatment.
A novel technology that utilizes light of different wavelengths to control cellular functions by inducing reversible assembly and disassembly of molecules has been developed. This breakthrough could ...
Biomedical research typically follows a familiar path: developing treatments that block, enhance or mutate certain signaling pathways, genes or proteins to change the function of different cells in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback